RXR agonist, Bexarotene, effectively reduces drug resistance via regulation of RFX1 in embryonic carcinoma cells.
Biochim Biophys Acta Mol Cell Res
; 1870(7): 119510, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37301270
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma
/
Drug Resistance, Neoplasm
/
Regulatory Factor X1
Limits:
Humans
Language:
En
Journal:
Biochim Biophys Acta Mol Cell Res
Year:
2023
Document type:
Article
Affiliation country:
India